Analgesics (Pharmacies) - Haiti

  • Haiti
  • Revenue in the Analgesics market is projected to reach US$47.07m in 2024.
  • Revenue is expected to show an annual growth rate (CAGR 2024-2028) of 5.50%, resulting in a market volume of US$58.31m by 2028.
  • In global comparison, most revenue will be generated in China (US$5,028.00m in 2024).
  • In relation to total population figures, per person revenues of US$3.97 are generated in 2024.

Key regions: Europe, United States, Canada, India, South Korea

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Analgesics (Pharmacies) market in Haiti is experiencing steady growth due to several factors. Customer preferences for pain relief medications, along with trends in the market and local special circumstances, are contributing to this development. Customer preferences in Haiti indicate a growing demand for analgesics in pharmacies. As the population becomes more aware of the importance of pain management, there is an increasing tendency to seek over-the-counter pain relief medications. Customers prefer the convenience of purchasing analgesics from pharmacies, where they can receive guidance from trained professionals and access a wide range of products. This preference for pharmacies as a source of analgesics is driving the growth of the market. Trends in the market also contribute to the development of the Analgesics (Pharmacies) market in Haiti. One notable trend is the rising prevalence of chronic pain conditions. As the population ages and lifestyles change, the incidence of chronic pain conditions such as arthritis and back pain is increasing. This trend is driving the demand for analgesics in pharmacies, as individuals seek relief from their symptoms. Additionally, there is a growing trend towards self-medication, with individuals taking a more proactive approach to managing their pain. This trend further boosts the demand for analgesics in pharmacies. Local special circumstances in Haiti also play a role in the development of the Analgesics (Pharmacies) market. Haiti has a relatively high poverty rate, and access to healthcare services can be limited for many individuals. As a result, pharmacies often serve as a primary point of care for minor ailments and pain management. The affordability and accessibility of analgesics in pharmacies make them a preferred option for individuals seeking pain relief. Additionally, the presence of a large number of pharmacies in urban areas ensures that individuals have easy access to these medications. Underlying macroeconomic factors also contribute to the growth of the Analgesics (Pharmacies) market in Haiti. The country's improving economic conditions have resulted in an increase in disposable income for many individuals. This allows them to afford over-the-counter analgesics and contribute to the growth of the market. Additionally, the expansion of the healthcare sector in Haiti, with increased investment in infrastructure and services, has also contributed to the growth of the Analgesics (Pharmacies) market. The availability of healthcare services and the growing emphasis on pain management have created a favorable environment for the market's development. In conclusion, the Analgesics (Pharmacies) market in Haiti is developing due to customer preferences for pain relief medications, trends in the market, local special circumstances, and underlying macroeconomic factors. As the population becomes more aware of the importance of pain management and seeks convenient access to analgesics, the demand for these products in pharmacies is increasing. The rising prevalence of chronic pain conditions, the trend towards self-medication, and the affordability and accessibility of pharmacies further contribute to the market's growth. Additionally, Haiti's improving economic conditions and expanding healthcare sector create a favorable environment for the development of the market.

Methodology

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)